Zoetis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. 

CEO
Kristin C. Peck
CEOKristin C. Peck
Employees
14,500
Employees14,500
Headquarters
Parsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded
1952
Founded1952
Employees
14,500
Employees14,500

ZTS Key Statistics

Market cap
32.21B
Market cap32.21B
Price-Earnings ratio
12.57
Price-Earnings ratio12.57
Dividend yield
2.71%
Dividend yield2.71%
Average volume
7.55M
Average volume7.55M
High today
$77.97
High today$77.97
Low today
$76.02
Low today$76.02
Open price
$77.40
Open price$77.40
Volume
5.86M
Volume5.86M
52 Week high
$161.77
52 Week high$161.77
52 Week low
$72.38
52 Week low$72.38

Stock Snapshot

With a market cap of 32.21B, Zoetis(ZTS) trades at $77.00. The stock has a price-to-earnings ratio of 12.57 and currently yields dividends of 2.71%.

During the trading session on 2026-06-24, Zoetis(ZTS) shares reached a daily high of $77.97 and a low of $76.02. At a current price of $77.00, the stock is +1.3% higher than the low and still -1.2% under the high.

Trading activity shows a volume of 5.86M, compared to an average daily volume of 7.55M.

Over the past 52 weeks, Zoetis(ZTS) stock has traded between a high of $161.77 and a low of $72.38.

Over the past 52 weeks, Zoetis(ZTS) stock has traded between a high of $161.77 and a low of $72.38.

ZTS News

MarketWatch 1d
Zoetis Inc. stock underperforms Monday when compared to competitors - MarketWatch

...

Zoetis Inc. stock underperforms Monday when compared to competitors - MarketWatch
The Motley Fool 2d
The Best Stocks to Invest $1,000 in Right Now

Long-term investing is about building your portfolio brick by brick. That could mean adding money weekly, monthly, or whenever you have extra cash on hand. How...

The Best Stocks to Invest $1,000 in Right Now
Simply Wall St 3d
Zoetis Stock Could Be 15.3% Undervalued After Class Action Lawsuits

Zoetis (ZTS) is back in focus after a series of securities class action lawsuits accused the company of misleading investors about weakening demand, safety conc...

Zoetis Stock Could Be 15.3% Undervalued After Class Action Lawsuits

Analyst ratings

55%

of 20 ratings
Buy
55%
Hold
45%
Sell
0%

More ZTS News

Simply Wall St 5d
Does Class Action Scrutiny of Companion Animal Disclosures Change The Bull Case For Zoetis?

In recent months, multiple law firms have launched or reminded investors of securities class action lawsuits against Zoetis, alleging the company misled the mar...

Does Class Action Scrutiny of Companion Animal Disclosures Change The Bull Case For Zoetis?
Nasdaq 5d
Zoetis Surpasses Market Returns: Some Facts Worth Knowing

Zoetis (ZTS) ended the recent trading session at $168.82, demonstrating a +1.5% change from the preceding day's closing price. The stock outperformed the S&P 50...

Zoetis Surpasses Market Returns: Some Facts Worth Knowing

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.